Pharma Avanti SRL
Pharma Avanti reported total assets of €2.08m at the end of the 2025 financial year (annual accounts filed with the NBB on 05 Jun 2026).
By total assets for 2025, Pharma Avanti ranks among the 10,000 largest of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Pharma Avanti shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -12 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Avanti's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Jun 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 25 Jul 2022
Pharma Avanti's financial analysis
- Solvency55.3%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Avanti
Pharma Avanti's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0691.683.343
- VAT number
- BE0691683343
- Peppol
- Registered · 0208:0691683343 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Mar 2018
- Registered office
- 9600 Ronse
- Latest accounts
- 2025 · filed on 05 Jun 2026
- Activity
- Activities of holding companies (NACE 64210)
Pharma Avanti (SRL) has been based in Ronse since 2018, active in: activities of holding companies. For 2025, it reports a net profit of 2,369 € and equity of €1.15m; its revenue is not published. Its solvency stands at 55.3%, below the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharma Avanti
Companies in the same business, of comparable size and area, outside its group.
- Vandre Activities of holding companies Ledegem · balance sheet €2.08m
- JDN Management Activities of holding companies Ninove · balance sheet €2.07m
- Proman Holding Activities of holding companies Kortrijk · balance sheet €2.08m
- Walmack Holding Activities of holding companies Remicourt · balance sheet €2.07m
- 5 On the Road Activities of holding companies Ghent · balance sheet €2.07m
- The Chocolate House Activities of holding companies Ingelmunster · balance sheet €2.07m
- Moneyspender Activities of holding companies Chaumont-Gistoux · balance sheet €2.08m
- WPMI Activities of holding companies Peer · balance sheet €2.07m
Frequently asked questions about Pharma Avanti
What is the revenue of Pharma Avanti?
Pharma Avanti files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Avanti?
In Belgium, the VAT number is the company number prefixed with BE: BE0691683343 for Pharma Avanti, if the company is VAT-registered. Its company number (CBE) is 0691.683.343.
Where is the registered office of Pharma Avanti?
According to the CBE register, the registered office of Pharma Avanti is in 9600 Ronse.
What is the equity of Pharma Avanti?
At the close of the 2025 financial year, the equity of Pharma Avanti amounts to 1,147,849 €, a solvency of 55.3% of total assets.
Who manages Pharma Avanti?
The register lists 2 active mandates at Pharma Avanti. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Pharma Avanti within its sector?
By total assets for 2025, Pharma Avanti ranks among the 10,000 largest of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year.
The full file of Pharma Avanti
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →